Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of ENSYSCE BIOSCIENCES, INC.. A complete text table follows the diagram.
SEC Form 10-Q · Quarter ended 2026-03-31 · automatically extracted reported figures
Swipe to explore
Values are reported Inline XBRL facts from the downloaded SEC 10-Q. This normalized extraction does not add company-specific segment storytelling or manual allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Revenue | 1 | $1 | — |
| Gross profit | 2 | $1 | 100% gross margin |
| Operating income | 3 | $3.6M | 371% operating margin |
| Research & development | 3 | $3.3M | — |
| SG&A | 3 | $1.2M | — |
| Net income | 5 | $3.6M | 370% net margin |
| From | To | Value |
|---|---|---|
| Revenue | Gross profit | $1 |
| Gross profit | Operating income | $3.6M |
| Gross profit | Research & development | $3.3M |
| Gross profit | SG&A | $1.2M |
| Operating income | Net income | $3.6M |